Logo image of PCOR

PROCORE TECHNOLOGIES INC (PCOR) Stock Fundamental Analysis

USA - NYSE:PCOR - US74275K1088 - Common Stock

69.6 USD
-1 (-1.42%)
Last: 9/12/2025, 8:07:18 PM
69.6 USD
0 (0%)
After Hours: 9/12/2025, 8:07:18 PM
Fundamental Rating

4

Taking everything into account, PCOR scores 4 out of 10 in our fundamental rating. PCOR was compared to 280 industry peers in the Software industry. While PCOR seems to be doing ok healthwise, there are quite some concerns on its profitability. PCOR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year PCOR was profitable.
PCOR had a positive operating cash flow in the past year.
In the past 5 years PCOR always reported negative net income.
In the past 5 years PCOR always reported a positive cash flow from operatings.
PCOR Yearly Net Income VS EBIT VS OCF VS FCFPCOR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

PCOR has a Return On Assets (-7.12%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of -11.72%, PCOR is in line with its industry, outperforming 47.14% of the companies in the same industry.
Industry RankSector Rank
ROA -7.12%
ROE -11.72%
ROIC N/A
ROA(3y)-10.51%
ROA(5y)-11.86%
ROE(3y)-16.78%
ROE(5y)-18.88%
ROIC(3y)N/A
ROIC(5y)N/A
PCOR Yearly ROA, ROE, ROICPCOR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

PCOR's Gross Margin of 80.17% is amongst the best of the industry. PCOR outperforms 82.14% of its industry peers.
PCOR's Gross Margin has been stable in the last couple of years.
PCOR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 80.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.52%
GM growth 5Y0.14%
PCOR Yearly Profit, Operating, Gross MarginsPCOR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

6

2. Health

2.1 Basic Checks

PCOR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PCOR has more shares outstanding
PCOR has more shares outstanding than it did 5 years ago.
PCOR has a better debt/assets ratio than last year.
PCOR Yearly Shares OutstandingPCOR Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M
PCOR Yearly Total Debt VS Total AssetsPCOR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

PCOR has an Altman-Z score of 7.65. This indicates that PCOR is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of PCOR (7.65) is better than 80.36% of its industry peers.
PCOR has a debt to FCF ratio of 0.38. This is a very positive value and a sign of high solvency as it would only need 0.38 years to pay back of all of its debts.
PCOR has a Debt to FCF ratio of 0.38. This is in the better half of the industry: PCOR outperforms 79.29% of its industry peers.
PCOR has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
PCOR has a better Debt to Equity ratio (0.02) than 61.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.38
Altman-Z 7.65
ROIC/WACCN/A
WACC11.15%
PCOR Yearly LT Debt VS Equity VS FCFPCOR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 1.29 indicates that PCOR should not have too much problems paying its short term obligations.
PCOR has a Current ratio of 1.29. This is comparable to the rest of the industry: PCOR outperforms 42.14% of its industry peers.
PCOR has a Quick Ratio of 1.29. This is a normal value and indicates that PCOR is financially healthy and should not expect problems in meeting its short term obligations.
PCOR's Quick ratio of 1.29 is in line compared to the rest of the industry. PCOR outperforms 43.21% of its industry peers.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.29
PCOR Yearly Current Assets VS Current LiabilitesPCOR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

6

3. Growth

3.1 Past

The earnings per share for PCOR have decreased strongly by -12.63% in the last year.
The Revenue has grown by 16.08% in the past year. This is quite good.
Measured over the past years, PCOR shows a very strong growth in Revenue. The Revenue has been growing by 31.83% on average per year.
EPS 1Y (TTM)-12.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10.26%
Revenue 1Y (TTM)16.08%
Revenue growth 3Y30.79%
Revenue growth 5Y31.83%
Sales Q2Q%13.92%

3.2 Future

Based on estimates for the next years, PCOR will show a very strong growth in Earnings Per Share. The EPS will grow by 33.07% on average per year.
The Revenue is expected to grow by 14.19% on average over the next years. This is quite good.
EPS Next Y38.41%
EPS Next 2Y34.27%
EPS Next 3Y33.07%
EPS Next 5YN/A
Revenue Next Year13.7%
Revenue Next 2Y13.21%
Revenue Next 3Y13.99%
Revenue Next 5Y14.19%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
PCOR Yearly Revenue VS EstimatesPCOR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B
PCOR Yearly EPS VS EstimatesPCOR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 1.5 2

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 83.86 indicates a quite expensive valuation of PCOR.
PCOR's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.30, PCOR is valued quite expensively.
Based on the Price/Forward Earnings ratio of 41.07, the valuation of PCOR can be described as expensive.
PCOR's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.73, PCOR is valued quite expensively.
Industry RankSector Rank
PE 83.86
Fwd PE 41.07
PCOR Price Earnings VS Forward Price EarningsPCOR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as PCOR.
Industry RankSector Rank
P/FCF 135.56
EV/EBITDA N/A
PCOR Per share dataPCOR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PCOR's earnings are expected to grow with 33.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.18
PEG (5Y)N/A
EPS Next 2Y34.27%
EPS Next 3Y33.07%

0

5. Dividend

5.1 Amount

No dividends for PCOR!.
Industry RankSector Rank
Dividend Yield N/A

PROCORE TECHNOLOGIES INC

NYSE:PCOR (9/12/2025, 8:07:18 PM)

After market: 69.6 0 (0%)

69.6

-1 (-1.42%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)10-28 2025-10-28/amc
Inst Owners95.62%
Inst Owner Change-2.53%
Ins Owners8.9%
Ins Owner Change1.22%
Market Cap10.45B
Analysts77.24
Price Target82.86 (19.05%)
Short Float %8.11%
Short Ratio6.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)27.54%
Min EPS beat(2)23.64%
Max EPS beat(2)31.45%
EPS beat(4)3
Avg EPS beat(4)-7.25%
Min EPS beat(4)-91.52%
Max EPS beat(4)31.45%
EPS beat(8)7
Avg EPS beat(8)63.01%
EPS beat(12)11
Avg EPS beat(12)68.81%
EPS beat(16)14
Avg EPS beat(16)54.52%
Revenue beat(2)2
Avg Revenue beat(2)1.14%
Min Revenue beat(2)0.63%
Max Revenue beat(2)1.65%
Revenue beat(4)3
Avg Revenue beat(4)0.65%
Min Revenue beat(4)-0.56%
Max Revenue beat(4)1.65%
Revenue beat(8)7
Avg Revenue beat(8)1.37%
Revenue beat(12)11
Avg Revenue beat(12)2.11%
Revenue beat(16)15
Avg Revenue beat(16)2.52%
PT rev (1m)0.48%
PT rev (3m)5.27%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10.82%
EPS NY rev (1m)6.73%
EPS NY rev (3m)6.05%
Revenue NQ rev (1m)0.07%
Revenue NQ rev (3m)-0.52%
Revenue NY rev (1m)0.99%
Revenue NY rev (3m)1.07%
Valuation
Industry RankSector Rank
PE 83.86
Fwd PE 41.07
P/S 8.48
P/FCF 135.56
P/OCF 63.28
P/B 8.59
P/tB 26.82
EV/EBITDA N/A
EPS(TTM)0.83
EY1.19%
EPS(NY)1.69
Fwd EY2.43%
FCF(TTM)0.51
FCFY0.74%
OCF(TTM)1.1
OCFY1.58%
SpS8.21
BVpS8.11
TBVpS2.6
PEG (NY)2.18
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.12%
ROE -11.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 80.17%
FCFM 6.26%
ROA(3y)-10.51%
ROA(5y)-11.86%
ROE(3y)-16.78%
ROE(5y)-18.88%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.52%
GM growth 5Y0.14%
F-Score5
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.38
Debt/EBITDA N/A
Cap/Depr 85.55%
Cap/Sales 7.15%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.29
Quick Ratio 1.29
Altman-Z 7.65
F-Score5
WACC11.15%
ROIC/WACCN/A
Cap/Depr(3y)77.64%
Cap/Depr(5y)76.37%
Cap/Sales(3y)6.24%
Cap/Sales(5y)5.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10.26%
EPS Next Y38.41%
EPS Next 2Y34.27%
EPS Next 3Y33.07%
EPS Next 5YN/A
Revenue 1Y (TTM)16.08%
Revenue growth 3Y30.79%
Revenue growth 5Y31.83%
Sales Q2Q%13.92%
Revenue Next Year13.7%
Revenue Next 2Y13.21%
Revenue Next 3Y13.99%
Revenue Next 5Y14.19%
EBIT growth 1Y-46.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year98.07%
EBIT Next 3Y50.54%
EBIT Next 5YN/A
FCF growth 1Y6974.59%
FCF growth 3Y138.66%
FCF growth 5YN/A
OCF growth 1Y252.36%
OCF growth 3Y74.8%
OCF growth 5YN/A